NUOPTIMA > SaaS Podcast > How Drug Hunter Grew to $2M ARR

How Drug Hunter Grew to $2M ARR

May 15, 2024

Interviewee Introduction: Dennis Hu

This episode features an interview with Dennis, a chemist-turned-founder who launched Drug Hunter, a B2B subscription service for drug discovery professionals. Dennis discusses his academic background, including a fast-tracked PhD from Stanford and work in the biotech industry, before founding Drug Hunter. He shares insights on the initial challenges, such as pricing strategies and deciding on product features, and how the company has grown to serve over 150 institutions with an ARR exceeding 2 million dollars. Key takeaways include the importance of focusing on what customers willing to pay the most demand, and how pivoting from offering consultancy to prioritizing a subscription model was crucial for growth. Additionally, Dennis touches on his journey navigating product development and hiring, along with the impact of organic growth and potential future directions for Drug Hunter.

Growth Strategy Call

Book a call with one of our growth experts to discover the best way to grow your business

Contact Us